EVLO — Evelo Biosciences Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Evelo Biosciences rises after CEO steps down
Evelo Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Brief: Evelo Biosciences announces succession plan
Brief: Evelo Biosciences reports Q2 results
Evelo Biosciences Inc expected to post a loss of 43 cents a share - Earnings Preview
Evelo Biosciences Inc expected to post a loss of 43 cents a share - Earnings Preview
Brief: Evelo Biosciences Announces Appointment Of Marella Thorell As Chief Financial Officer
Brief: Evelo Biosciences - Entered Into Sales Agreement With Cowen Dated July 1, Relating To Sale Of Shares Of Common Stock Offered By Prospectus Supplement
Brief: Evelo Biosciences Inc - On May 31, 2022, Luca Scavo Delivered His Resignation As The Chief Financial Officer Of Co Effective June 3, 2022
Brief: Evelo Biosciences Entered Into Securities Purchase Agreement - SEC Filing
Evelo Biosciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: Evelo Biosciences Q1 Loss Per Share $0.56
Evelo Biosciences Inc expected to post a loss of 58 cents a share - Earnings Preview
Brief: Evelo Biosciences Provides Updated Guidance On Advancing Clinical Inflammation Programs
Brief: Evelo Biosciences Presents Late-Breaking Oral Abstract On Data From Phase 2 Trial Of EDP1815 In Psoriasis
Evelo Biosciences Inc reports results for the quarter ended in December - Earnings Summary
Brief: Evelo Biosciences Inc Says As Of December 31, 2021, Cash And Cash Equivalents Were $68.4 Million
Evelo Biosciences Inc expected to post a loss of 61cents a share - Earnings Preview
Evelo Biosciences Inc expected to post a loss of 61 cents a share - Earnings Preview